Catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options.

We used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia.

Learn more about Our Hemophilia Programs.

A protease is an enzyme that cleaves target proteins. Learn more about Proteases.